SurvivorNet on MSN
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years
New long‑term results from the RUBY clinical trial show that adding immunotherapy (dostarlimab) to chemotherapy may help some people with advanced or recurrent endometrial cancer stay in remission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results